Nebacumab
Nebacumab (pronounced: ne-ba-cu-mab) is a monoclonal antibody designed for the treatment of various cancer types. It is a type of biological therapy that targets specific proteins on cancer cells to inhibit their growth and spread.
Etymology
The term "Nebacumab" is derived from the Latin words 'nebula' meaning cloud, and 'cumab' meaning antibody. This is in reference to the drug's function as an antibody that targets cancer cells, much like a cloud enveloping its target.
Usage
Nebacumab is used in the treatment of various types of cancer, including breast cancer, lung cancer, and colorectal cancer. It works by binding to specific proteins on the surface of cancer cells, inhibiting their growth and spread. This makes it a valuable tool in the fight against cancer.
Related Terms
- Monoclonal Antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells. Nebacumab is a type of monoclonal antibody.
- Biological Therapy: Treatment to stimulate or restore the ability of the immune system to fight infection and disease. Nebacumab is a type of biological therapy.
- Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells. Nebacumab is used in the treatment of cancer.
See Also
External links
- Medical encyclopedia article on Nebacumab
- Wikipedia's article - Nebacumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski